Researchers have reported on a new utility of the PET tracer florbetapir. They found that the tracer can distinguish frontotemporal dementia (FTD) from Alzheimer’s disease and the cognitively normal elderly.  This ability removes the need for a separate scan to identify FTD, which can cause significant stress in such patients. {read more here}

Higher tumor volume at baseline and worse responses to chemotherapy after four cycles — measured with PET scans — can predict poorer overall and event-free survival among patients with peripheral  T-cell lymphoma (PTCL), according to researchers from Memorial Sloan Kettering Cancer Center in New York. {read more here}

Thanks to its high specificity, fluoroethyl-tyrosine (FET)-PET can help confirm the success of surgical procedures performed on pediatric patients with brain and spinal cord tumors to ensure that no residual tumor is left behind, according to a study published online January 25 in the Journal of Nuclear Medicine. {read more here}

Researchers have the first PET scan-documented case of improvement in brain metabolism in Alzheimer’s disease in a patient treated with hyperbaric oxygen therapy (HBOT). {read more here}